Dantas AP et al. |
Sphingosine 1-phosphate and control of vascular tone. |
2003 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:12742827
|
Asada S et al. |
Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis. |
2008 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:18978195
|
Tao R et al. |
High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate. |
2010 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:20061542
|
Adamson RH et al. |
Albumin modulates S1P delivery from red blood cells in perfused microvessels: mechanism of the protein effect. |
2014 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:24531813
|
Vessey DA et al. |
P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels. |
2011 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:21685263
|
Vessey DA et al. |
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. |
2009 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:19648253
|
Landeen LK et al. |
Sphingosine-1-phosphate receptor expression in cardiac fibroblasts is modulated by in vitro culture conditions. |
2007 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:17337593
|
Means CK et al. |
Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. |
2007 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:17293497
|
Zhang F et al. |
Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction. |
2016 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:26589326
|
Zeng Y et al. |
Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding. |
2014 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:24285115
|
Stone ML et al. |
Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury. |
2015 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:25910934
|
Nishiuma T et al. |
Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. |
2008 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:18359884
|
Karmouty-Quintana H et al. |
Treatment with a sphingosine-1-phosphate analog inhibits airway remodeling following repeated allergen exposure. |
2012 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:22287614
|
Sun X et al. |
Functional promoter variants in sphingosine 1-phosphate receptor 3 associate with susceptibility to sepsis-associated acute respiratory distress syndrome. |
2013 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:23911438
|
Yin Z and Watsky MA |
Chloride channel activity in human lung fibroblasts and myofibroblasts. |
2005 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:15681397
|
Bhattacharya M et al. |
IQGAP1 is necessary for pulmonary vascular barrier protection in murine acute lung injury and pneumonia. |
2012 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:22561460
|
Choi S et al. |
A genetic variant of cortactin linked to acute lung injury impairs lamellipodia dynamics and endothelial wound healing. |
2015 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:26361873
|
Szczepaniak WS et al. |
S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. |
2010 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:20435688
|
Wadgaonkar R et al. |
Differential regulation of sphingosine kinases 1 and 2 in lung injury. |
2009 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:19168577
|
Schweitzer KS et al. |
Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. |
2015 |
Am. J. Physiol. Lung Cell Mol. Physiol. |
pmid:25979079
|